Global Oxaliplatin Injection Market Outlook 2021

Global Oxaliplatin Injection Market Outlook 2021

Table of Contents
1 Oxaliplatin Injection Market Overview
1.1 Product Overview and Scope of Oxaliplatin Injection
1.2 Oxaliplatin Injection Segment by Solvent
1.2.1 Global Oxaliplatin Injection Sales Growth Rate Comparison by Solvent (2020-2026)
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Oxaliplatin Injection Segment by Application
1.3.1 Oxaliplatin Injection Sales Comparison by Application: (2020-2026)
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Global Oxaliplatin Injection Market Size Estimates and Forecasts
1.4.1 Global Oxaliplatin Injection Revenue 2015-2026
1.4.2 Global Oxaliplatin Injection Sales 2015-2026
1.4.3 Oxaliplatin Injection Market Size by Region: 2020 Versus 2026
2 Global Oxaliplatin Injection Market Competition by Manufacturers
2.1 Global Oxaliplatin Injection Sales Market Share by Manufacturers (2015-2020)
2.2 Global Oxaliplatin Injection Revenue Share by Manufacturers (2015-2020)
2.3 Global Oxaliplatin Injection Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oxaliplatin Injection Manufacturing Sites, Area Served, Product Type
2.5 Oxaliplatin Injection Market Competitive Situation and Trends
2.5.1 Oxaliplatin Injection Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Oxaliplatin Injection Players (Opinion Leaders)
3 Oxaliplatin Injection Retrospective Market Scenario by Region
3.1 Global Oxaliplatin Injection Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Oxaliplatin Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Oxaliplatin Injection Market Facts & Figures by Country
3.3.1 North America Oxaliplatin Injection Sales by Country
3.3.2 North America Oxaliplatin Injection Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oxaliplatin Injection Market Facts & Figures by Country
3.4.1 Europe Oxaliplatin Injection Sales by Country
3.4.2 Europe Oxaliplatin Injection Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oxaliplatin Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Oxaliplatin Injection Sales by Region
3.5.2 Asia Pacific Oxaliplatin Injection Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oxaliplatin Injection Market Facts & Figures by Country
3.6.1 Latin America Oxaliplatin Injection Sales by Country
3.6.2 Latin America Oxaliplatin Injection Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oxaliplatin Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Oxaliplatin Injection Sales by Country
3.7.2 Middle East and Africa Oxaliplatin Injection Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oxaliplatin Injection Historic Market Analysis by Solvent
4.1 Global Oxaliplatin Injection Sales Market Share by Solvent (2015-2020)
4.2 Global Oxaliplatin Injection Revenue Market Share by Solvent (2015-2020)
4.3 Global Oxaliplatin Injection Price Market Share by Solvent (2015-2020)
4.4 Global Oxaliplatin Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Oxaliplatin Injection Historic Market Analysis by Application
5.1 Global Oxaliplatin Injection Sales Market Share by Application (2015-2020)
5.2 Global Oxaliplatin Injection Revenue Market Share by Application (2015-2020)
5.3 Global Oxaliplatin Injection Price by Application (2015-2020)
6 Company Profiles and Key Figures in Oxaliplatin Injection Business
6.1 Sanofi-Aventis
6.1.1 Corporation Information
6.1.2 Sanofi-Aventis Description, Business Overview
6.1.3 Sanofi-Aventis Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi-Aventis Products Offered
6.1.5 Sanofi-Aventis Recent Development
6.2 Yakult honsha
6.2.1 Yakult honsha Corporation Information
6.2.2 Yakult honsha Description, Business Overview
6.2.3 Yakult honsha Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Yakult honsha Products Offered
6.2.5 Yakult honsha Recent Development
6.3 Dr Reddy's laboratories
6.3.1 Dr Reddy's laboratories Corporation Information
6.3.2 Dr Reddy's laboratories Description, Business Overview
6.3.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dr Reddy's laboratories Products Offered
6.3.5 Dr Reddy's laboratories Recent Development
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description, Business Overview
6.4.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sun Pharmaceutical Products Offered
6.4.5 Sun Pharmaceutical Recent Development
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description, Business Overview
6.5.3 Teva Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Teva Products Offered
6.5.5 Teva Recent Development
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description, Business Overview
6.6.3 Fresenius Kabi Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Fresenius Kabi Products Offered
6.6.5 Fresenius Kabi Recent Development
6.7 Hospira(Pfizer)
6.6.1 Hospira(Pfizer) Corporation Information
6.6.2 Hospira(Pfizer) Description, Business Overview
6.6.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hospira(Pfizer) Products Offered
6.7.5 Hospira(Pfizer) Recent Development
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description, Business Overview
6.8.3 Mylan Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Mylan Products Offered
6.8.5 Mylan Recent Development
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Corporation Information
6.9.2 Jiangsu Hengrui Medicine Description, Business Overview
6.9.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Jiangsu Hengrui Medicine Products Offered
6.9.5 Jiangsu Hengrui Medicine Recent Development
6.10 Nanjing Pharmaceutical Factory
6.10.1 Nanjing Pharmaceutical Factory Corporation Information
6.10.2 Nanjing Pharmaceutical Factory Description, Business Overview
6.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Nanjing Pharmaceutical Factory Products Offered
6.10.5 Nanjing Pharmaceutical Factory Recent Development
6.11 Jiangsu Aosaikang Pharmaceutical
6.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Jiangsu Aosaikang Pharmaceutical Products Offered
6.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Corporation Information
6.12.2 Qilu Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.12.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Qilu Pharmaceutical Products Offered
6.12.5 Qilu Pharmaceutical Recent Development
6.13 Hisun Pharmaceutical
6.13.1 Hisun Pharmaceutical Corporation Information
6.13.2 Hisun Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.13.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Hisun Pharmaceutical Products Offered
6.13.5 Hisun Pharmaceutical Recent Development
6.14 Lunan Pharmaceutical
6.14.1 Lunan Pharmaceutical Corporation Information
6.14.2 Lunan Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.14.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Lunan Pharmaceutical Products Offered
6.14.5 Lunan Pharmaceutical Recent Development
6.15 Luoxin
6.15.1 Luoxin Corporation Information
6.15.2 Luoxin Oxaliplatin Injection Description, Business Overview
6.15.3 Luoxin Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Luoxin Products Offered
6.15.5 Luoxin Recent Development
6.16 Halfsky Pharmacy
6.16.1 Halfsky Pharmacy Corporation Information
6.16.2 Halfsky Pharmacy Oxaliplatin Injection Description, Business Overview
6.16.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Halfsky Pharmacy Products Offered
6.16.5 Halfsky Pharmacy Recent Development
6.17 YRPG
6.17.1 YRPG Corporation Information
6.17.2 YRPG Oxaliplatin Injection Description, Business Overview
6.17.3 YRPG Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.17.4 YRPG Products Offered
6.17.5 YRPG Recent Development
6.18 Hainan Jinrui Pharmaceutical
6.18.1 Hainan Jinrui Pharmaceutical Corporation Information
6.18.2 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Hainan Jinrui Pharmaceutical Products Offered
6.18.5 Hainan Jinrui Pharmaceutical Recent Development
6.19 Jari Pharmaceutical
6.19.1 Jari Pharmaceutical Corporation Information
6.19.2 Jari Pharmaceutical Oxaliplatin Injection Description, Business Overview
6.19.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Jari Pharmaceutical Products Offered
6.19.5 Jari Pharmaceutical Recent Development
6.20 Chiatai Tianqing
6.20.1 Chiatai Tianqing Corporation Information
6.20.2 Chiatai Tianqing Oxaliplatin Injection Description, Business Overview
6.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Chiatai Tianqing Products Offered
6.20.5 Chiatai Tianqing Recent Development
7 Oxaliplatin Injection Manufacturing Cost Analysis
7.1 Oxaliplatin Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oxaliplatin Injection
7.4 Oxaliplatin Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oxaliplatin Injection Distributors List
8.3 Oxaliplatin Injection Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Oxaliplatin Injection Market Estimates and Projections by Solvent
10.1.1 Global Forecasted Sales of Oxaliplatin Injection by Solvent (2021-2026)
10.1.2 Global Forecasted Revenue of Oxaliplatin Injection by Solvent (2021-2026)
10.2 Oxaliplatin Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oxaliplatin Injection by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Oxaliplatin Injection by Application (2021-2026)
10.3 Oxaliplatin Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oxaliplatin Injection by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Oxaliplatin Injection by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oxaliplatin Injection Sales (K Units) Growth Rate Comparison by Solvent (2015-2026)
Table 2. Global Oxaliplatin Injection Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Oxaliplatin Injection Market Size by Solvent (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Oxaliplatin Injection Manufacturers Covered in This Study
Table 5. Global Oxaliplatin Injection Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Oxaliplatin Injection Sales Share by Manufacturers (2015-2020)
Table 7. Global Oxaliplatin Injection Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Oxaliplatin Injection Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Oxaliplatin Injection Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Oxaliplatin Injection Sales Sites and Area Served
Table 11. Manufacturers Oxaliplatin Injection Product Types
Table 12. Global Oxaliplatin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oxaliplatin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin Injection as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Oxaliplatin Injection Players
Table 16. Global Oxaliplatin Injection Sales (K Units) by Region (2015-2020)
Table 17. Global Oxaliplatin Injection Sales Market Share by Region (2015-2020)
Table 18. Global Oxaliplatin Injection Revenue (Million US$) by Region (2015-2020)
Table 19. Global Oxaliplatin Injection Revenue Market Share by Region (2015-2020)
Table 20. North America Oxaliplatin Injection Sales by Country (2015-2020) (K Units)
Table 21. North America Oxaliplatin Injection Sales Market Share by Country (2015-2020)
Table 22. North America Oxaliplatin Injection Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Oxaliplatin Injection Revenue Market Share by Country (2015-2020)
Table 24. Europe Oxaliplatin Injection Sales by Country (2015-2020) (K Units)
Table 25. Europe Oxaliplatin Injection Sales Market Share by Country (2015-2020)
Table 26. Europe Oxaliplatin Injection Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Oxaliplatin Injection Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Oxaliplatin Injection Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Oxaliplatin Injection Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Oxaliplatin Injection Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Oxaliplatin Injection Revenue Market Share by Region (2015-2020)
Table 32. Latin America Oxaliplatin Injection Sales by Country (2015-2020) (K Units)
Table 33. Latin America Oxaliplatin Injection Sales Market Share by Country (2015-2020)
Table 34. Latin America Oxaliplatin Injection Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Oxaliplatin Injection Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Oxaliplatin Injection Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Oxaliplatin Injection Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Oxaliplatin Injection Revenue Market Share by Country (2015-2020)
Table 40. Global Oxaliplatin Injection Sales (K Units) by Solvent (2015-2020)
Table 41. Global Oxaliplatin Injection Sales Share by Solvent (2015-2020)
Table 42. Global Oxaliplatin Injection Revenue (Million US$) by Solvent (2015-2020)
Table 43. Global Oxaliplatin Injection Revenue Share by Solvent (2015-2020)
Table 44. Global Oxaliplatin Injection Price (US$/Unit) by Solvent (2015-2020)
Table 45. Global Oxaliplatin Injection Sales (K Units) by Application (2015-2020)
Table 46. Global Oxaliplatin Injection Sales Market Share by Application (2015-2020)
Table 47. Global Oxaliplatin Injection Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Sanofi-Aventis Main Product
Table 52. Sanofi-Aventis Recent Development
Table 53. Yakult honsha Corporation Information
Table 54. Yakult honsha Description and Business Overview
Table 55. Yakult honsha Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Yakult honsha Main Product
Table 57. Yakult honsha Recent Development
Table 58. Dr Reddy's laboratories Corporation Information
Table 59. Dr Reddy's laboratories Description and Business Overview
Table 60. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Dr Reddy's laboratories Main Product
Table 62. Dr Reddy's laboratories Recent Development
Table 63. Sun Pharmaceutical Corporation Information
Table 64. Sun Pharmaceutical Description and Business Overview
Table 65. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Sun Pharmaceutical Main Product
Table 67. Sun Pharmaceutical Recent Development
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Teva Main Product
Table 72. Teva Recent Development
Table 73. Fresenius Kabi Corporation Information
Table 74. Fresenius Kabi Description and Business Overview
Table 75. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Fresenius Kabi Main Product
Table 77. Fresenius Kabi Recent Development
Table 78. Hospira(Pfizer) Corporation Information
Table 79. Hospira(Pfizer) Description and Business Overview
Table 80. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Hospira(Pfizer) Main Product
Table 82. Hospira(Pfizer) Recent Development
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Mylan Main Product
Table 87. Mylan Recent Development
Table 88. Jiangsu Hengrui Medicine Corporation Information
Table 89. Jiangsu Hengrui Medicine Description and Business Overview
Table 90. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Jiangsu Hengrui Medicine Main Product
Table 92. Jiangsu Hengrui Medicine Recent Development
Table 93. Nanjing Pharmaceutical Factory Corporation Information
Table 94. Nanjing Pharmaceutical Factory Description and Business Overview
Table 95. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Nanjing Pharmaceutical Factory Main Product
Table 97. Nanjing Pharmaceutical Factory Recent Development
Table 98. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 99. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 100. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Jiangsu Aosaikang Pharmaceutical Main Product
Table 102. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 103. Qilu Pharmaceutical Corporation Information
Table 104. Qilu Pharmaceutical Description and Business Overview
Table 105. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Qilu Pharmaceutical Main Product
Table 107. Qilu Pharmaceutical Recent Development
Table 108. Hisun Pharmaceutical Corporation Information
Table 109. Hisun Pharmaceutical Description and Business Overview
Table 110. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Hisun Pharmaceutical Main Product
Table 112. Hisun Pharmaceutical Recent Development
Table 113. Lunan Pharmaceutical Corporation Information
Table 114. Lunan Pharmaceutical Description and Business Overview
Table 115. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Lunan Pharmaceutical Main Product
Table 117. Lunan Pharmaceutical Recent Development
Table 118. Luoxin Corporation Information
Table 119. Luoxin Description and Business Overview
Table 120. Luoxin Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Luoxin Main Product
Table 122. Luoxin Recent Development
Table 123. Halfsky Pharmacy Corporation Information
Table 124. Halfsky Pharmacy Description and Business Overview
Table 125. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Halfsky Pharmacy Main Product
Table 127. Halfsky Pharmacy Recent Development
Table 128. YRPG Corporation Information
Table 129. YRPG Description and Business Overview
Table 130. YRPG Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. YRPG Main Product
Table 132. YRPG Recent Development
Table 133. Hainan Jinrui Pharmaceutical Corporation Information
Table 134. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 135. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 136. Hainan Jinrui Pharmaceutical Main Product
Table 137. Hainan Jinrui Pharmaceutical Recent Development
Table 138. Jari Pharmaceutical Corporation Information
Table 139. Jari Pharmaceutical Description and Business Overview
Table 140. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 141. Jari Pharmaceutical Main Product
Table 142. Jari Pharmaceutical Recent Development
Table 143. Chiatai Tianqing Corporation Information
Table 144. Chiatai Tianqing Description and Business Overview
Table 145. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 146. Chiatai Tianqing Main Product
Table 147. Chiatai Tianqing Recent Development
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Oxaliplatin Injection Distributors List
Table 151. Oxaliplatin Injection Customers List
Table 152. Oxaliplatin Injection Market Trends
Table 153. Oxaliplatin Injection Opportunities and Drivers
Table 154. Oxaliplatin Injection Market Challenges
Table 155. Global Oxaliplatin Injection Sales (K Units) Forecast by Solvent (2021-2026)
Table 156. Global Oxaliplatin Injection Sales Market Share Forecast by Solvent (2021-2026)
Table 157. Global Oxaliplatin Injection Revenue (Million US$) Forecast by Solvent (2021-2026)
Table 158. Global Oxaliplatin Injection Revenue (Million US$) Market Share Forecast by Solvent (2021-2026)
Table 159. Global Oxaliplatin Injection Sales (K Units) Forecast by Application (2021-2026)
Table 160. Global Oxaliplatin Injection Revenue (Million US$) Forecast by Application (2021-2026)
Table 161. Global Oxaliplatin Injection Sales (K Units) Forecast by Region (2021-2026)
Table 162. Global Oxaliplatin Injection Sales Market Share Forecast by Region (2021-2026)
Table 163. Global Oxaliplatin Injection Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Global Oxaliplatin Injection Revenue Market Share Forecast by Region (2021-2026)
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Oxaliplatin Injection
Figure 2. Global Oxaliplatin Injection Sales Market Share by Solvent: 2020 VS 2026
Figure 3. Mannitol Product Picture
Figure 4. Glucose Solution Product Picture
Figure 5. Lactose Solution Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oxaliplatin Injection Consumption Market Share by Application: 2020 VS 2026
Figure 8. Colorectal Cancer
Figure 9. Stomach Cancer
Figure 10. Ovarian Cancer
Figure 11. Other
Figure 12. Global Oxaliplatin Injection Market Size 2015-2026 (US$ Million)
Figure 13. Global Oxaliplatin Injection Sales Capacity (K Units) (2015-2026)
Figure 14. Global Oxaliplatin Injection Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Oxaliplatin Injection Sales Share by Manufacturers in 2020
Figure 16. Global Oxaliplatin Injection Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oxaliplatin Injection Revenue in 2019
Figure 18. Oxaliplatin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Oxaliplatin Injection Sales Market Share by Region (2015-2020)
Figure 20. Global Oxaliplatin Injection Sales Market Share by Region in 2019
Figure 21. Global Oxaliplatin Injection Revenue Market Share by Region (2015-2020)
Figure 22. Global Oxaliplatin Injection Revenue Market Share by Region in 2019
Figure 23. North America Oxaliplatin Injection Sales Market Share by Country in 2019
Figure 24. North America Oxaliplatin Injection Revenue Market Share by Country in 2019
Figure 25. U.S. Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Oxaliplatin Injection Sales Market Share by Country in 2019
Figure 30. Europe Oxaliplatin Injection Revenue Market Share by Country in 2019
Figure 31. Germany Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Oxaliplatin Injection Sales Market Share by Region in 2019
Figure 42. Asia Pacific Oxaliplatin Injection Revenue Market Share by Region in 2019
Figure 43. China Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Oxaliplatin Injection Sales Market Share by Country in 2019
Figure 66. Latin America Oxaliplatin Injection Revenue Market Share by Country in 2019
Figure 67. Mexico Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Oxaliplatin Injection Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Oxaliplatin Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Oxaliplatin Injection Sales Market Share by Country in 2019
Figure 74. Middle East and

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs